Brief: RepliCel therapy for pattern baldness proceeds to clinical trial launch in Japan

Replicel Life Sciences

21/07/2016 13:02

July 21 (Reuters) - RepliCel Life Sciences Inc  RP.V : 
    * RCH-01 product cleared by Japanese regulatory authorities 
for use in clinical research study launching now in Japan 
    * Study financed by Shiseido company, each product being 
injected to be manufactured by Shiseido at facility in Kobe, 
Japan 
    * Replicel's cell therapy for pattern baldness proceeds to 
clinical trial launch in Japan 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nMKWbsYcHa 
Further company coverage:  RP.V  
 
 (Bengaluru Newsroom: +1-646-223-8780)